InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,463.54
(
0.08%
)
US TECH 100
18,493.20
(
-0.14%
)
Dow Jones
40,539.93
(
-0.12%
)
Brent Oil
78.67
(
-0.61%
)
Bitcoin
66,562.43
(
-0.39%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

$heff

Send PM Follow Ignore
Followers 3421
Posts 32269
Boards Moderated 1
Alias Born 07/08/2006

$heff

Re: $heff post# 52100

Thursday, 03/01/2012 3:16:20 AM

Thursday, March 01, 2012 3:16:20 AM

Post# of 97239
ONXX..$38.32 Target enrollment reached for the ASPIRE trial, evaluating carfilzomib + lenalidomide/ dexamethasone in pts with relapsed multiple myeloma. (Medscape Oncology)

Sheff's Station...All Aboard...Sign Up Here!

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up